Jim Cramer Says This Stock Up 23% In A Month Is ‘A Great Speculative Buy’
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Biohaven Ltd (NYSE: BHVN) is a "great speculative buy."
Benzinga’s Top Ratings Upgrades, Downgrades For January 4, 2023
Upgrades UBS upgraded the previous rating for Trane Technologies PLC (NYSE:TT) from Neutral to Buy. For the third…
JP Morgan Initiates Coverage On Biohaven with Overweight Rating, Announces Price Target of $23
JP Morgan analyst Tessa Romero initiates coverage on Biohaven (NYSE:BHVN) with a Overweight rating and announces Price Target of $23.
Jim Cramer Recommends These 5 Healthcare Stocks For 2023: ‘Biggest Winners Were Boring, Consistent Operators’
Prominent market commentator Jim Cramer has recommended five healthcare stocks which he believes should be on investors’ shopping list for 2023.
Jim Cramer Says This Stock Is Dynamite: ‘I Do Not Want You To Do A Thing Other Than Ride It’
On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Williams Companies, Inc. (NYSE: WMB) is "terrific." He recommended buying the stock.
Biohaven Pharmaceutical Q3 EPS $(1.75) Up From $(1.91) YoY
Biohaven Pharmaceutical (NYSE:BHVN) reported quarterly losses of $(1.75) per share. This is a 8.38 percent increase over losses of $(1.91) per share from the same period last year.
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
Gainers
Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.
Moderna, Amazon, Tesla, And Other Big Gainers From Friday
U.S. stocks closed higher on Friday, with the Dow Jones gaining around 750 points. Here is the list of some big stocks recording gains in the previous session.
Biohaven Late Thursday Announces Pricing Of Public Offering Of 25M Common Shares At a Price Of $10.50/Share
Biohaven Ltd. (NYSE:BHVN) ("Biohaven") announced today the pricing of the public offering of 25,000,000 of its common shares, at a public offering price of $10.50 per common share. Biohaven has
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
Gainers
Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains.